Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Schott Pharma Schweiz AG is currently overseeing 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 4 distinct examiners, which indicates that each pending matter is being reviewed by a different individual. This direct correlation between actions and examiners suggests a diverse set of perspectives will be applied to the company's current patent applications.
The portfolio's activity spans 3 distinct art units, showing that the company's technical reach extends across several specialized divisions within the patent office. The busiest examiner is ACKUN, JACOB K, who is managing 1 pending office action. This distribution across 3 distinct art units implies that the company must navigate varying examination standards and technical requirements across its active matters. Practitioners should prepare for a varied prosecution experience as each matter is subject to the independent judgment of different reviewers.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ACKUN, JACOB K | 1 | 56.9% | +3.5% |
| OSINSKI, BRADLEY JAMES | 1 | 78.5% | +11.3% |
| THOMAN, EVELYN ANNE | 1 | 100.0% | +0.0% |
| NGUYEN, ANDREW H | 1 | 75.1% | +42.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18358985 | GLASS SYRINGE BARREL WITH INCREASED FLANGE BREAKING RESISTANCE | THOMAN, EVELYN ANNE | — |
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18521236 | CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID, AS WELL AS A CANNULA ASSEMBLY AND CLOSURE SYSTEM FOR A CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID | OSINSKI, BRADLEY JAMES | — |
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 3736 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172935 | ASSEMBLY FOR PHARMACEUTICAL CONTAINERS FOR REDUCING CONTACT BETWEEN CONTAINERS AND SIDEWALLS OF ASSEMBLY | ACKUN, JACOB K | 3736 | §103 | Non-Final OA | — | Pending | Apr 08, 2025 |
| 18521236 | CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID, AS WELL AS A CANNULA ASSEMBLY AND CLOSURE SYSTEM FOR A CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID | OSINSKI, BRADLEY JAMES | 3783 | DP | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18358985 | GLASS SYRINGE BARREL WITH INCREASED FLANGE BREAKING RESISTANCE | THOMAN, EVELYN ANNE | 3783 | §103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | 3741 | §102§103 | Non-Final OA | — | Pending | Apr 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial